U.S. Paper and Forestry Products Stock News

Genuine Parts (GPC) opened 2026 with Q1 revenue of US$6.3b and basic EPS of US$1.37, setting a clean reference point after a volatile run through 2025. Over recent quarters the company has seen revenue move from US$5.9b in Q1 2025 and US$5.8b in Q4 2024 to the current US$6.3b print, while basic EPS has ranged from US$1.40 in Q1 2025 to a Q4 2025 loss of US$4.39 per share before rebounding this quarter. This leaves investors to weigh how much of the margin pressure and the very low 0.2%...

Bridgewater Bancshares (BWB) opened 2026 with Q1 total revenue of US$45.0 million and basic EPS of US$0.59, setting a clear reference point for how its profitability is shaping up against recent history. Over the past year, revenue increased from US$30.8 million in Q1 2025 to US$45.0 million in Q1 2026, while trailing twelve month basic EPS moved from US$1.05 at the end of Q4 2024 to US$1.81 at the end of Q1 2026. This gives investors a clearer view of earnings power as profit margins change...

East West Bancorp (EWBC) opened 2026 with Q1 revenue of US$715.8 million and basic EPS of US$2.59, alongside net income of US$357.8 million. Trailing twelve month figures reached US$2.79 billion in revenue, US$10.07 in EPS and US$1.39 billion in net income. The company has reported an increase in trailing revenue from US$2.39 billion and EPS of US$8.39 in Q4 2024 to US$2.79 billion and EPS of US$10.07 in Q1 2026, which may lead investors to evaluate recent earnings and margin strength as key...

Bank OZK (NasdaqGS:OZK) provided a $2 million grant to support an affordable housing initiative in Austin, Texas. The funding helped facilitate the opening of a 100 unit community in partnership with the Federal Home Loan Bank of Dallas. For anyone following regional banks, this move gives you another data point on how Bank OZK approaches its business beyond core lending and deposit gathering. Affordable housing is a major policy focus in many U.S. cities, and Austin is one of the markets...

Investors may be wondering whether PBF Energy at around US$40.46 is still offering value after a strong run, or if most of the opportunity has already played out. The stock has delivered a 41.8% return year to date and 164.7% over the last year, even though the past month included a 13.2% decline and the last week a 0.2% slip. Recent coverage has focused on how refinery operators like PBF Energy are responding to shifting margins, capacity utilization trends and changing fuel demand, which...

Wondering if EnerSys, at a last close of US$202.10, is still reasonably priced after a strong run, or if you are arriving late to the story. The stock has posted returns of 4.2% over 7 days, 18.0% over 30 days, 34.1% year to date, 144.8% over 1 year, 159.0% over 3 years and 127.5% over 5 years, which raises questions about how much future upside or downside is now priced in. Recent coverage has focused on EnerSys as a battery and energy storage supplier tied to long term electrification and...

Xtrackers has adopted Tradeweb's iNAVs for its Europe listed ETFs, expanding Tradeweb's role in real time ETF valuation. With this move, Tradeweb now supplies independent iNAVs for over half of the assets under management in European listed ETFs. The development further embeds Tradeweb Markets (NasdaqGS:TW) in the core data infrastructure of the European ETF market. Tradeweb Markets, best known for its electronic trading platforms across fixed income, ETFs and derivatives, is steadily...

Investors may be wondering whether Halozyme Therapeutics, at around US$68 per share, still offers value or if most of the upside is already priced in. The stock has a recent 7 day return of 1.6%, a 30 day return of 7.9%, a year to date return of a 2.7% decline, a 1 year return of 17.5%, and a 3 year return a little above a 2x multiple. This naturally raises questions about how current expectations line up with fundamentals. Recent news flow around Halozyme Therapeutics has focused on its...

Evommune (NYSE:EVMN) has filed a significant shelf registration, creating the ability to raise capital over time. The filing positions the company to access funding when it chooses, rather than through a single, immediate offering. The move is material for investors because it can influence Evommune's financial flexibility and funding plans. For investors tracking NYSE:EVMN, the shelf registration comes after a period of strong share price performance. The stock is currently at $28.07, with...

If you are wondering whether Sprinklr's current share price reflects its true worth, you are not alone. This comes after a tough stretch for the stock. Over the last year, the share price return sits at a 26.0% decline. This includes a 28.8% decline year to date, contributing to a 57.0% decline over three years. Recent coverage has focused on how sentiment around customer experience software names is shifting, with investors paying closer attention to profitability, cash generation and...

Wondering if Northwest Bancshares at around US$13.22 is offering solid value or just looks inexpensive on the surface? This article walks through what the current price may be implying about the stock. The share price has seen mixed short term moves, with a 1.2% decline over the last 7 days but an 8.3% gain over 30 days and returns of 10.4% year to date and 22.2% over 1 year. Recent company developments, regulatory updates or sector headlines can all influence how investors think about banks...

If you are trying to work out whether Pagaya Technologies at about US$14.32 is genuinely good value or just riding a narrative, the recent numbers give you plenty to think about. The stock has returned 10.1% over the last 7 days, 34.6% over the last 30 days, 52.7% over the last year and 43.8% over 3 years, although the year to date return of 35.7% and 5 year return of 87.8% show that the ride has not been smooth. Recent coverage around Pagaya Technologies has focused on its role as a...

Wondering whether Churchill Downs at around US$90.84 is a bargain or a value trap? This article breaks down what the current share price might be implying about the stock. The stock has been mixed recently, with a 1.2% decline over the last week, an 8.5% gain over the last month, and returns of an 18.9% decline year to date and an 11.5% decline over the last year. Those returns sit against a longer backdrop where the share price shows a 27.7% decline over three years and a 15.7% decline over...

Wondering if Ameriprise Financial is offering good value at its current price, or if the recent run means you might be late to the story? The stock last closed at US$461.08, with a 5.0% gain over 30 days, a small 0.2% decline over 7 days, and returns of 93.7% over 5 years and 65.8% over 3 years. These figures may catch your eye if you are weighing growth potential against risk. Recent coverage around Ameriprise Financial has focused on its role in the broader capital markets sector and how...

DoubleVerify Holdings (NYSE:DV) has entered a new partnership with Spectrum Reach to launch the first Certified Transparent Streaming program. The collaboration focuses on program level ad transparency across streaming TV and CTV campaigns. This move aims to give advertisers clearer insight into where their ads appear within specific streaming programs. For investors tracking NYSE:DV, the development comes with the stock trading around $10.66, after a 5.3% gain over the past week and 6.1%...

Over the last 7 days, the United States market has risen by 1.3% and is up 35% over the past year, with earnings expected to grow by 16% annually in the coming years. In this environment of robust growth, identifying stocks that are potentially undervalued can offer opportunities for investors seeking value amidst a rising market.

The United States market has shown robust performance, rising 1.3% over the last week and 35% over the past year, with earnings expected to grow by 16% annually. In such a dynamic environment, identifying small-cap stocks like Alto Ingredients that have strong growth potential and unique market positions can be key to uncovering hidden opportunities.

Wondering if EPR Properties at about US$56.56 is still offering value after its recent run, or if most of the easy gains are already behind it. The stock shows returns of 0.9% over 7 days, 12.1% over 30 days, 11.4% year to date, 22.1% over 1 year, 72.7% over 3 years, and 66.0% over 5 years, which provides useful context before weighing up what the current price might imply. Recent coverage around EPR Properties has focused on its role within the Specialized REITs space and investor interest...

Investors may be wondering whether Ducommun, at its recent close of around US$141.48, still offers value or whether most of the opportunity is already reflected in the price. The stock has posted returns of 0.1% over the last week, 17.3% over the last month, 46.2% year to date and 157.6% over the past year, with 3 year and 5 year returns of 179.1% and 143.9% respectively. Recent coverage has focused on Ducommun's role within the capital goods sector and investor interest in companies exposed...

If you are wondering whether STAAR Surgical's current share price still offers value or if the recent excitement has already been priced in, this article breaks down what the market might be implying about the stock. The share price closed at US$24.92, with returns of 2.0% over 7 days, 42.2% over 30 days, 5.6% year to date and 45.1% over 1 year, but with much weaker 3 year and 5 year returns of 63.5% and 81.7% declines. These price moves have arrived alongside fresh attention on the business...

If you are looking at BlackLine and wondering whether the current share price reflects fair value or an opportunity, the next sections will walk through the key signals that matter. The stock last closed at US$31.56, with returns of 1.7% over 7 days, a 19.3% decline over 30 days, a 41.3% decline year to date, and a 30.0% decline over the last year, which may influence how you think about both potential growth and risk. Recent coverage has focused on BlackLine as investors reassess software...

Onto Innovation (NYSE:ONTO) announced a collaboration with Rigaku Holdings Corporation focused on next generation semiconductor process control solutions. As part of the agreement, Onto is investing $710 million for a 27% equity stake in Rigaku and gains the right to nominate a director. The partnership combines Onto's AI enabled metrology software with Rigaku's X ray technologies to target hybrid metrology for advanced logic and memory manufacturing. For investors tracking NYSE:ONTO, this...

Linkage Global Inc ( NASDAQ:LGCB ) insiders who acquired shares over the previous 12 months, can probably afford to...

General Electric (GE) opened 2026 with Q1 revenue of US$12.4b and basic EPS of US$1.84, setting the tone for how the year is starting to shape up after a strong 2025 earnings run. The company has seen quarterly revenue move from US$9.9b in Q1 2025 to US$12.4b in Q1 2026, while basic EPS has stayed in a tight band around the mid US$1 range. This puts more attention on how efficiently that top line is being converted into profit. Against that backdrop, investors are likely to focus on how...